Navigation Links
Leading for Growth in the New Economic Reality Includes Vision and Innovation
Date:6/16/2009

DuPont CEO Ellen Kullman outlines leading in a dynamic and unpredictable world at Wharton Leadership Conference.

Philadelphia, PA (Vocus) June 16, 2009 -- As the global recession has changed the landscape of many markets DuPont serves, the company is well-positioned to deliver dynamic innovations to meet the evolving markets demand because “change is in our DNA,” said DuPont CEO Ellen J. Kullman at the 13th Annual Wharton Leadership Conference here today.

“There is no playbook for what the world is experiencing right now, but several leadership principles have surfaced in our experience at DuPont and seem particularly appropriate to the dynamic and uncertain conditions we currently face today,” Kullman said. “At DuPont, change is in our DNA. The four leadership principles that have emerged are: focus on what you can control, adopt a new trajectory, communicate and maintain pride around your mission.”

During its 207 years, DuPont has evolved through three transformations, emerging stronger each time as the company continues to innovate through economic downturns, Kullman said. She noted that nylon was discovered during the Great Depression. “None of that happened by accident. It took leaders who had a vision and were absolutely determined to not waste a good crisis,” Kullman said.

Today, as a market-driven science company, DuPont continues its legacy of delivering innovation during challenging times. Kullman said the company’s research and development efforts – including more than three-quarters of its R&D budget -- are focused on three major global “megatrends:” the need for increasing food productivity, decreasing dependence on fossil fuels and protecting lives. DuPont delivered more than $10 billion in sales from new products that are less than five years old in 2008. In the first quarter of 2009, the company commercialized more than 500 new products – nearly double compared to the first quarter of 2008.

“At DuPont, we have often been successful by stepping out of our comfort zone and adopting a new trajectory,” Kullman said. “We are not afraid to aggressively pursue fundamental change, whether it is new business models, new scientific or technological platforms or other basic change.”

Several specific examples highlighted by Kullman included innovative business models successfully executed in the company’s Safety Resources and Applied BioSciences businesses; new market-driven technologies for Kevlar® and Nomex® high performance materials; and a strong focus on tailoring innovations to meet specific needs in emerging economies, like China and India.

“In the new economic reality, DuPont continues to deliver market-back science to make the world a better and safer place,” Kullman said. “We must be prepared not for the world the way it was before the recession, but prepare to succeed in the very different world that we’ll encounter when the recovery eventually comes.”

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries and regions, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

###

Read the full story at http://www.prweb.com/releases/Dupon_Wharton/Leadership_Conference/prweb2540534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
4. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
7. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leading for Growth in the New Economic Reality Includes Vision and Innovation
(Date:12/8/2016)... OXFORD, England , December 8, 2016 /PRNewswire/ ... (OGT), das Unternehmen für Molekulargenetik, erweitert seine Palette ... SureSeq myPanel™ NGS Custom FH Panels, das ein ... Hypercholesterinämie (FH) ermöglicht. Das Panel bietet eine Erkennung ... Number Variations (CNV) mit einem einzigen kleinen Panel ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox ... response to client demand KbioBox developed a sophisticated “3 click” gene dditing off ... accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered by the ...
(Date:12/8/2016)... ... ... This CAST literature review and report looks at problems caused by the current ... in countries that are major global commodity exporters and importers, which show that asynchrony ... level presence (LLP) puts large volumes of trade worth billions of dollars at risk. ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):